Early administration of hemostatic therapy such as prothrombin complex concentrates (PCCs), fibrinogen concentrates, fresh frozen plasma, platelets and antifibrolytics may be critical for preventing complex coagulopathies and progression to severe, life-threatening hemorrhage [105]. Here, F2 is linked to blood coagulation disease.